SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-143822
Filing Date
2012-03-30
Accepted
2012-03-30 16:46:52
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d283543d10k.htm 10-K 1365686
2 FIRST AMENDMENT TO THE UNITED STATES LICENSE AND COLLABORATION AGREEMENT d283543dex1030.htm EX-10.30 23497
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d283543dex231.htm EX-23.1 3787
4 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302 d283543dex311.htm EX-31.1 9790
5 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 302 d283543dex312.htm EX-31.2 9960
6 CERTIFICATION OF THE COMPANY'S CEO AND CFO PURSUANT TO SECTION 906 d283543dex321.htm EX-32.1 5092
13 GRAPHIC g283543g15t58.jpg GRAPHIC 43329
  Complete submission text file 0001193125-12-143822.txt   4349051

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tspt-20111231.xml EX-101.INS 653277
8 XBRL TAXONOMY EXTENSION SCHEMA tspt-20111231.xsd EX-101.SCH 17843
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tspt-20111231_cal.xml EX-101.CAL 33382
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tspt-20111231_def.xml EX-101.DEF 16144
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tspt-20111231_lab.xml EX-101.LAB 145058
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tspt-20111231_pre.xml EX-101.PRE 96065
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51967 | Film No.: 12729882
SIC: 2834 Pharmaceutical Preparations